|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Gross written premiums | |||||
| Ceded written premiums | |||||
| Net written premiums | |||||
| Change in unearned premiums | |||||
| Net earned premiums | |||||
| Net investment income | |||||
| Net realized and unrealized gains on investments | |||||
| Commission and other income | |||||
| Total revenues | |||||
| Expenses: | |||||
| Losses and loss adjustment expenses | |||||
| Acquisition expenses, net of ceding commissions and fronting fees | |||||
| Other underwriting expenses | |||||
| Interest expense | |||||
| Total expenses | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Other comprehensive income, net: | |||||
| Net unrealized gains (losses) on securities available for sale | |||||
| Total comprehensive income | |||||
| Per Share Data: | |||||
| Basic earnings per share (in dollars per share) | |||||
| Diluted earnings per share (in dollars per share) | |||||
| Weighted-average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...